MAPT and Alzheimer disease: AD etiology is significantly influenced by tau hyperphosphorylation, mainly at serine (Ser) or threonine (Thr), so molecules that reduce phospho-tau accumulation may represent an effective treatment strategy (Bloom, 2014).